padrão (~JJ)_(JJ_NN_IN_JJ_NN)_(~NN) 	onde (~JJ) é para não chocar com a regra 1.2

#Sem nome próprio
1. Java: (?:[\\w-/]*_(?:[^J].?.?\\s|J[^J].?\\s)|^)([\\w-/]*_JJ[RS]?\\s[\\w-/]*_NN[S]?\\s[\\w-/]*_IN\\s[\\w-/]*_JJ[RS]?\\s[\\w-/]*_NN[S]?)(?:\\s[\\w-/]*_(?:[^N]..?|N[^N].?)|\\s\\._|\\s,_|\\s:_|\\s;_|$)
	1.1 descarta prefixo JJ_NN_IN: (?:[\\w-/]*_JJ[RS]?\\s[\\w-/]*_NN[S]?\\s[\\w-/]*_IN\\s)([\\w-/]*_JJ[RS]?\\s[\\w-/]*_NN[S]?)
2. Perl: (?:[\w-/]*_(?:[^J].?.?\s|J[^J].?\s)|^)([\w-/]*_JJ[RS]?\s[\w-/]*_NN[S]?\s[\w-/]*_IN\s[\w-/]*_JJ[RS]?\s[\w-/]*_NN[S]?)(?:\s[\w-/]*_(?:[^N]..?|N[^N].?)|\s\._|\s,_|\s:_|\s;_|$)
	2.1 descarta prefixo JJ_NN_IN: (?:[\w-/]*_JJ[RS]?\s[\w-/]*_NN[S]?\s[\w-/]*_IN\s)([\w-/]*_JJ[RS]?\s[\w-/]*_NN[S]?)
	// \w  Casa letras, dígitos, ou '_'.
	// 1 e 2 são equivalentes
	// Regra termina com ponto final, vírgula, ponto e vírgula, dois pontos ou $.
	// Não teve termo com nome próprio (NNP)

Sentences Examples:

Despite_IN a_DT sustained_JJ increase_NN in_IN HbF_NNP level_NN and_CC an_DT increase_NN in_IN hydroxyurea_NN doses_NNS to_TO 30_CD mg\/kg_NN per_IN day_NN ,_, a_DT girl_NN aged_VBN 13_CD months_NNS at_IN inclusion_NN with_IN previous_JJ history_NN of_IN splenic_JJ sequestration_NN ,_, was_VBD hospitalized_VBN 20_CD times_NNS during_IN these_DT 2_CD years_NNS of_IN HU_NNP therapy_NN and_CC continued_VBD to_TO present_VB multiple_JJ vaso-occlusive_JJ crises_NNS and_CC dactylitis_NNS during_IN the_DT first_JJ year_NN of_IN HU_NNP ._. 

In_IN particular_JJ ,_, the_DT Belgian_JJ experience_NN with_IN chronic_JJ transfusion_NN is_VBZ very_RB disappointing_JJ because_IN of_IN a_DT high_JJ rate_NN of_IN severe_JJ alloimmunization_NN ,_, mainly_RB explained_VBN by_IN the_DT absence_NN of_IN blood_NN donors_NNS of_IN African_JJ origin_NN ._. 

One_CD patient_NN died_VBD of_IN a_DT fatal_JJ episode_NN of_IN splenic_JJ sequestration_NN before_IN completing_VBG 2_CD years_NNS of_IN treatment_NN ._. 

Before_IN hydroxyurea_NN treatment_NN ,_, three_CD of_IN them_PRP had_VBD splenomegaly_RB and_CC two_CD a_DT previous_JJ history_NN of_IN splenic_JJ sequestration_NN ._. 

We_PRP ,_, therefore_RB ,_, recommend_VB careful_JJ evaluation_NN of_IN spleen_NN size_NN and_CC blood_NN tests_NNS at_IN each_DT evaluation_NN in_IN children_NNS with_IN previous_JJ splenomegaly_NN or_CC a_DT past_JJ history_NN of_IN splenic_JJ sequestration_NN before_IN starting_VBG hydroxyurea_NN ._. 

The_DT primary_JJ causes_NNS of_IN death_NN were_VBD respiratory_JJ failure_NN from_IN pulmonary_JJ emboli_NNS -LRB-_-LRB- bone_NN marrow_NN ,_, fat_NN ,_, or_CC thrombotic_JJ -RRB-_-RRB- in_IN six_CD patients_NNS and_CC bronchopneumonia_NN in_IN six_CD ._. 

The_DT causes_NNS of_IN death_NN in_IN the_DT remaining_VBG patients_NNS were_VBD pulmonary_JJ hemorrhage_NN ,_, cor_FW pulmonale_FW ,_, hypovolemic_JJ shock_NN from_IN splenic_JJ sequestration_NN ,_, overwhelming_JJ sepsis_NN ,_, intracranial_JJ hemorrhage_NN ,_, and_CC seizure_NN ._. 

Ex. 
Verdadeiro Positivo:
	hypovolemic_JJ shock_NN from_IN splenic_JJ sequestration_NN ,_, 
	high_JJ rate_NN of_IN severe_JJ alloimmunization_NN ,_, 